Basilea Pharmaceutica AG
BPMUF
$71.00
-$0.60-0.84%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.29M | 15.27M | 9.58M | 8.79M | 32.37M |
| Total Depreciation and Amortization | 1.78M | 1.78M | 526.10K | 482.80K | 1.60M |
| Total Amortization of Deferred Charges | 76.40K | 76.30K | 282.50K | 259.20K | 74.00K |
| Total Other Non-Cash Items | 1.40M | 1.40M | 3.96M | 3.64M | -1.98M |
| Change in Net Operating Assets | 5.87M | 5.87M | -376.40K | -345.40K | 75.20K |
| Cash from Operations | 24.43M | 24.40M | 13.98M | 12.82M | 32.14M |
| Capital Expenditure | -1.44M | -1.44M | -194.60K | -178.50K | -707.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | 0.00 |
| Other Investing Activities | -93.30K | -93.10K | -56.40K | -51.70K | -16.50K |
| Cash from Investing | -1.53M | -1.53M | -250.90K | -230.30K | -724.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 92.50K | 92.50K | 253.50K | 253.50K | 73.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.57M | -3.57M | -7.49M | -7.49M | -84.50K |
| Cash from Financing | -4.35M | -4.35M | -8.77M | -8.05M | -12.50K |
| Foreign Exchange rate Adjustments | -9.40K | -9.40K | -6.70K | -6.10K | -33.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.54M | 18.51M | 4.95M | 4.54M | 31.37M |